INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne Muscular Dystrophy January 25, 2023
First Wave BioPharma Announces Expansion of Adrulipase Intellectual Property Portfolio January 25, 2023